These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells. Lee J; Kim JS; Cho HI; Jo SR; Jang YK Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887001 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2 Bhan A; Ansari KI; Chen MY; Jandial R Cancer Res; 2021 Jun; 81(12):3200-3214. PubMed ID: 33941612 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II). Sekirnik R; Rose NR; Thalhammer A; Seden PT; Mecinović J; Schofield CJ Chem Commun (Camb); 2009 Nov; (42):6376-8. PubMed ID: 19841782 [TBL] [Abstract][Full Text] [Related]
8. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein. Van Rechem C; Black JC; Abbas T; Allen A; Rinehart CA; Yuan GC; Dutta A; Whetstine JR J Biol Chem; 2011 Sep; 286(35):30462-30470. PubMed ID: 21757720 [TBL] [Abstract][Full Text] [Related]
9. Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy. Giri NC; Passantino L; Sun H; Zoroddu MA; Costa M; Maroney MJ Biochemistry; 2013 Jun; 52(24):4168-83. PubMed ID: 23692052 [TBL] [Abstract][Full Text] [Related]
10. Dioxygen Binding in the Active Site of Histone Demethylase JMJD2A and the Role of the Protein Environment. Cortopassi WA; Simion R; Honsby CE; França TC; Paton RS Chemistry; 2015 Dec; 21(52):18983-92. PubMed ID: 26577067 [TBL] [Abstract][Full Text] [Related]
11. JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells. He Y; Yi X; Zhang Z; Luo H; Li R; Feng X; Fang ZM; Zhu XH; Cheng W; Jiang DS; Zhao F; Wei X Clin Epigenetics; 2022 Aug; 14(1):101. PubMed ID: 35964071 [TBL] [Abstract][Full Text] [Related]
12. Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks. Bayo J; Tran TA; Wang L; Peña-Llopis S; Das AK; Martinez ED Cell Rep; 2018 Oct; 25(4):1040-1050.e5. PubMed ID: 30355483 [TBL] [Abstract][Full Text] [Related]
18. Tetrazolylhydrazides as Selective Fragment-Like Inhibitors of the JumonjiC-Domain-Containing Histone Demethylase KDM4A. Rüger N; Roatsch M; Emmrich T; Franz H; Schüle R; Jung M; Link A ChemMedChem; 2015 Nov; 10(11):1875-83. PubMed ID: 26337137 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the PHF8 Jumonji domain, an Nepsilon-methyl lysine demethylase. Yue WW; Hozjan V; Ge W; Loenarz C; Cooper CD; Schofield CJ; Kavanagh KL; Oppermann U; McDonough MA FEBS Lett; 2010 Feb; 584(4):825-30. PubMed ID: 20067792 [TBL] [Abstract][Full Text] [Related]
20. Structure of the Arabidopsis JMJ14-H3K4me3 Complex Provides Insight into the Substrate Specificity of KDM5 Subfamily Histone Demethylases. Yang Z; Qiu Q; Chen W; Jia B; Chen X; Hu H; He K; Deng X; Li S; Tao WA; Cao X; Du J Plant Cell; 2018 Jan; 30(1):167-177. PubMed ID: 29233856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]